Medicinal Product Shortages - update - 7 June 2023

Notice type: Advisory

Date: 07/06/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

 

Product

Active Ingredient(s)

Ceftazidime 1g Powder for solution for injection or infusion

PA0281/224/001

Pinewood Laboratories Ltd

Ceftazidime

Ezetimibe Rowa 10mg Tablets

PA0074/074/001

Rowa Pharmaceuticals Limited

Ezetimibe

Irbesartan Rowa 300mg Tablets

PA0074/080/003

Rowa Pharmaceuticals Limited

Irbesartan

Plavix 300mg Film-Coated Tablet

EU1/98/069/009

Sanofi Winthrop Industrie

Clopidogrel

Timoptol 0.5% w/v Eye Drops

PA0879/007/002

Santen OY

Timolol

Zanidip 10mg Film Coated Tablets

PA0812/001/001

Recordati Industria Chimica e Farmaceutica SpA

Lercanidipine

Zanidip 20mg Film Coated Tablets

PA0812/001/002

Recordati Industria Chimica e Farmaceutica SpA

Lercanidipine

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Aspirin 75mg Gastro Resistant Tablets

PA0126/246/001

Clonmel Healthcare Ltd

Aspirin

Atorvastatin Teva 20mg Film Coated Tablets

PA0749/110/002

Teva Pharma B.V.

Atorvastatin

Azactam 2g Powder for Solution for Injection or Infusion

PA0002/052/003

Bristol-Myers Squibb Pharmaceuticals uc

Aztreonam

Ciprofloxacin Teva 250mg Film Coated Tablets

(10 pack presentation only)

PA0749/031/002

Teva Pharma B.V.

Ciprofloxacin

Coversyl Arginine Plus 10mg/2.5mg Film Coated Tablets

PA0568/022/002

Les Laboratoires Servier

Perindopril & indapamide

Effentora 100mcg Buccal Tablets

EU/1/08/441/002

Teva B.V.

Fentanyl

Effentora 600mcg Buccal Tablets

EU/1/08/441/008

Teva B.V.

Fentanyl

Eligard 45mg powder and solvent for solution for injection

PA0812/005/003

Recordati Industria Chimica e Farmaceutica SpA

Leuprorelin

Fasturtec 7.5mg/5ml powder and solvent for concentrate for solution for injection

EU/1/00/170/002

Sanofi Winthrop Industrie

Rasburicase

Fucidin 20mg/g Ointment

PA0046/004/008

Leo Laboratories Limited

Sodium fusidate

Naraverg 2.5mg Film Coated Tablets

(6 & 12 pack)

PA0749/065/001

Teva Pharma B.V.

Naratriptan

Naropin 7.5 mg/ml solution for injection

PA1691/026/002

Aspen Pharma Trading Limited

Ropivacaine

Norditropin FlexPro 5mg/1.5ml Solution for Injection

PA0218/040/011

Novo Nordisk A/S

Somatropin

Omeprazole Teva 40mg Gastro Resistant Capsules

PA0749/160/003

Teva Pharma B.V.

Omeprazole

Pravastatin Sodium 40mg Tablets

PA0436/046/003

Norton Waterford

Pravastatin

Pregabalin Teva 50mg Hard Capsules

PA1986/001/002

Teva B.V.

Pregabalin

Rosuvastatin Mylan 40mg Film Coated Tablets

PA0577/140/004

McDermott Laboratories Ltd., T/A Gerard Laboratories

Rosuvastatin

Tostran 2% Gel

PA2288/001/004

Kyowa Kirin Holdings B.V.

Testosterone

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 



« Back